Latest News

Privi Speciality Chemicals Limited (PSCL) announced the outcomes of its Board Meeting held on June 14, 2025:

• The Board decided not to proceed with the previously approved capital raising of up to ₹1,000 crore via Qualified Institutions Placement (QIP). This decision was made due to the company's improved performance and sufficient cash accruals to meet capital expenditure requirements.
• The Board approved a scheme of amalgamation of Privi Fine Sciences Private Limited (PFSPL), a related party, and Privi Biotechnologies Private Limited (PBPL), a wholly owned subsidiary, with PSCL.
• Rationale for the amalgamation includes achieving merger and consolidation synergies, preserving and creating value for stakeholders, enhancing and strengthening PSCL's business, improving operational capabilities and market competitiveness, and expanding its product portfolio, particularly in green science chemistry.
• PFSPL, incorporated on April 13, 2021, is engaged in manufacturing speciality, aroma chemicals, and green science chemistry. It has an operational unit in Lote, Maharashtra, and land acquired in Jhagadia, Gujarat, for its green science business.
• PBPL is engaged in the manufacture, research, and development of biotechnology products, especially for flavours and fragrances.
• The amalgamation involves a share exchange ratio where every 1,000 fully paid equity shares of PFSPL (face value ₹10) will be exchanged for 7.9897 equity shares of PSCL (face value ₹10).
• The Proposed Scheme is subject to various approvals including from the National Company Law Tribunal (NCLT), Securities and Exchange Board of India (SEBI), Stock Exchanges (BSE and NSE), and the shareholders and creditors of PSCL, PFSPL, and PBPL.
• The company's shareholding pattern is expected to change upon the scheme becoming effective due to the issuance of securities to PFSPL shareholders.

Privi Speciality Chemicals Limited announced the outcome of its Board Meeting held on 3 May 2025.

• The Board approved the Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2025.
• For the financial year ended 31 March 2025, the company reported Standalone Revenue from Operations of ₹ 7,79,047 lakhs and a Net Profit of ₹ 18,852.64 lakhs. Consolidated Revenue from Operations was ₹ 8,17,795.15 lakhs with Net Profit attributable to owners of ₹ 18,685.30 lakhs.
• For the quarter ended 31 March 2025, Standalone Revenue from Operations was ₹ 59,489.93 lakhs and Net Profit was ₹ 6,571.37 lakhs. Consolidated Revenue from Operations was ₹ 61,355.03 lakhs with Net Profit attributable to owners of ₹ 6,647.92 lakhs.
• The Board recommended a Final Dividend of ₹ 5/- (50%) per Equity Share of ₹ 10/- each for the financial year ended 31 March 2025, subject to shareholder approval at the ensuing AGM.
• The 40th Annual General Meeting (AGM) is scheduled for Friday, 1 August 2025.
• The Record Date for determining the entitlement of shareholders for the recommended dividend is Thursday, 24 July 2025.
• The Register of Members and Share Transfer Books will remain closed from Friday, 25 July 2025 to Friday, 1 August 2025 (both inclusive) for the purpose of the AGM.
• The dividend, if approved by shareholders, will be paid within 30 days from the date of the 40th AGM.
• The Board also approved the re-appointment of M/s BSR & Co., LLP as Statutory Auditors for a second term of five years and the appointment of M/s. Rathi & Associates as Secretarial Auditors for a first term of five years, both subject to shareholder approval.

Privi Speciality Chemicals Limited has scheduled an Earnings Conference Call to discuss the operational and financial performance for the fourth quarter and full year ended March 31, 2025.

• Date: Tuesday, May 06, 2025
• Time: 4:30 p.m. IST
• Purpose: To discuss Q4 & FY25 results and take related questions.
• Participation: Management Team will be present.
• Access: Participants can join using provided primary and toll-free access numbers. Pre-registration link is also available.
• Transcript: A transcript of the call will be available on the company's website (www.privi.com) within five working days after the call concludes.